The U.S. Court of Appeals for the Federal Circuit has affirmed judgement in favor of Zydus Pharmaceuticals (USA) Inc., holding that its proposed generic version of Lialda does not infringe a U.S. Patent. Zydus is the first pharmaceutical company to file an abbreviated new drug application for a generic version...